QYUNS-B(02509),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02509 QYUNS-B

Closed 05-18 16:08:29

16.350

-0.810

-4.72%

High16.850	Low16.320	Vol117.60K
Open16.700	D1 Closing17.160	Amplitude3.09%
Mkt Cap3.68B	Tradable Cap3.68B	Total Shares225.00M
T/O1.96M	T/O Rate0.05%	Tradable Shares225.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"QYUNS-B","latestPrice":16.35,"timestamp":1779091709007,"preClose":17.16,"halted":0,"volume":117600,"delay":0,"changeRate":-0.04720279720279713,"floatShares":225000000,"shares":225000000,"eps":1.41,"marketStatus":"Closed","change":-0.81,"latestTime":"05-18 16:08:29","open":16.7,"high":16.85,"low":16.32,"amount":1958952,"amplitude":0.030886,"askPrice":16.49,"askSize":200,"bidPrice":16.35,"bidSize":1600,"shortable":3,"etf":0,"ttmEps":1.564286,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1779154200000},"marketStatusCode":5,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":17.16,"openAndCloseTimeList":[[1779067800000,1779076800000],[1779080400000,1779091200000]],"volumeRatio":0.378768,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509/tweets","defaultTab":"tweets","newsList":[{"id":"1131632209","title":"QYUNS-B (02509) Rises Over 3% Following Windward Bio's Completion of $165 Million Crossover Financing to Advance WIN027 Clinical Study","url":"https://stock-news.laohu8.com/highlight/detail?id=1131632209","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131632209?lang=en_us&edition=fundamental","pubTime":"2026-05-11 11:28","pubTimestamp":1778470108,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) saw its stock price increase by more than 3%. As of the latest update, the share price rose by 3.47% to HK$17.28, with a trading volume of HK$4.2084 million. On May 8, according to an...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VXUS","BK4585","02509","BK4588","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136994307","title":"Qyuns Therapeutics Rolls Out 10-Year Share Incentive Plan; Mandate Capped at 10% of Issued H Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1136994307","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136994307?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:44","pubTimestamp":1778244253,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (stock short name: QYUNS-B) released details of its 2026 Share Incentive Scheme, slated for shareholder approval at the 29 May 2026 AGM. Key Terms   • Scheme period: 10...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156173446","title":"Qyuns Therapeutics to Vote on Profit Distribution, KPMG Re-appointment and New 2026 Share Incentive Scheme at 29 May 2026 AGM","url":"https://stock-news.laohu8.com/highlight/detail?id=1156173446","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156173446?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:44","pubTimestamp":1778244246,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. will convene its 2026 annual general meeting at 10:00 a.m. on 29 May 2026 in Taizhou, Jiangsu. Shareholders will decide on 13 resolutions covering operational reports,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174436764","title":"Qyuns Therapeutics Tables Key AGM Proposals: No 2025 Dividend, HK$111.70 Million Proceeds Reallocated, Launches 10-Year Share Incentive Scheme","url":"https://stock-news.laohu8.com/highlight/detail?id=1174436764","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174436764?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:24","pubTimestamp":1778243062,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics will hold its 2025 annual general meeting on 29 May 2026 in Taizhou, Jiangsu.  The circular released on 8 May 2026 sets out eleven principal resolutions.  Key points are: • No 2025...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633957456","title":"Qyuns Therapeutics announces annual general meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2633957456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633957456?lang=en_us&edition=fundamental","pubTime":"2026-05-08 20:23","pubTimestamp":1778243015,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics will hold its annual general meeting in Taizhou City, Jiangsu Province on May 29, 2026.Shareholders will vote on 2025 reporting items, including board report, supervisors report, annual report with audited consolidated financial statements, profit distribution plan, director and supervisor remuneration plan, auditor appointment, and a proposed change in use of global offering proceeds.Special resolutions include proposed general mandates to issue shares and to repurchase H shares.Other items include dissolving supervisory committee with related governance document amendments, and adopting 2026 share incentive scheme with related mandate limits.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qyuns Therapeutics Co. Ltd","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260508:nNDL19G92p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631511466","title":"BRIEF-Qyuns Therapeutics To Subscribe PDB Wealth Product With RMB100 Million Principal","url":"https://stock-news.laohu8.com/highlight/detail?id=2631511466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631511466?lang=en_us&edition=fundamental","pubTime":"2026-04-29 20:37","pubTimestamp":1777466274,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics To Subscribe PDB Wealth Product With RMB100 Million PrincipalApril 29 (Reuters) - Qyuns Therapeutics Co Ltd 2509.HK:TO SUBSCRIBE PDB WEALTH PRODUCT WITH RMB100 MILLION PRINCIPAL MATURING OCT 29, 2026Further company coverage: 2509.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C0TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194992967","title":"QYUNS Deploys RMB270.00 Million Idle Funds into Low-Risk Structured Deposits at Shanghai Pudong Development Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=1194992967","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194992967?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:44","pubTimestamp":1777463043,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (“QYUNS”) disclosed three new subscriptions of principal-guaranteed, floating-yield structured deposits offered by Shanghai Pudong Development Bank (PDB), committing a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196338169","title":"QYUNS-B (02509) Allocates Funds to Wealth Management Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1196338169","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196338169?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:31","pubTimestamp":1777462260,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on April 29, 2026, to efficiently utilize its idle capital, the company entered into subscription agreements with SPD Bank to acquire several wealth management products...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631513878","title":"Qyuns Therapeutics Co Ltd - to Subscribe Pdb Wealth Product With RMB100 Mln Principal Maturing Oct 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2631513878","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631513878?lang=en_us&edition=fundamental","pubTime":"2026-04-29 19:23","pubTimestamp":1777461830,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260429:nFWN41C0TJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121393309","title":"Qyuns Therapeutics 2025年业绩大幅增长并实现首次全年盈利，全球化布局与核心产品管线齐头并进","url":"https://stock-news.laohu8.com/highlight/detail?id=1121393309","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121393309?lang=en_us&edition=fundamental","pubTime":"2026-04-27 17:31","pubTimestamp":1777282264,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd.（以下简称“公司”）于2025年度实现显著业绩增长和结构性进展，全年收入同比增长408.2%至人民币8.0696亿元（2024年：1.5879亿元），并从上一年度净亏损人民币3.4969亿元成功扭转为净利润人民币3.0744亿元，标志着公司首次实现全年盈利。...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Qyuns Therapeutics 2025年业绩大幅增长并实现首次全年盈利，全球化布局与核心产品管线齐头并进","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137432614","title":"QYUNS-B Shares Surge Over 8% Following Turn to Profit Last Year; Projected Sales of Key Product Near RMB 500 Million This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1137432614","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137432614?lang=en_us&edition=fundamental","pubTime":"2026-04-15 10:56","pubTimestamp":1776221806,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) rose more than 8% during the trading session. At the time of writing, the stock was up 7.22% to HK$20.78, with a turnover of HK$10.18 million. The company's 2025 results showed...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK4531","LU0049112450.USD","02509","BK4585","LU1235295612.USD","LX","BK4166","BK4588","LU1046422090.SGD","VXUS","BK4579"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179832135","title":"QYUNS-B Reports Stable Share Capital and Confirms Public Float Compliance for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1179832135","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179832135?lang=en_us&edition=fundamental","pubTime":"2026-04-09 18:48","pubTimestamp":1775731680,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. (QYUNS-B) submitted its Monthly Return for Equity Issuer to Hong Kong Exchanges and Clearing Limited on 9 April 2026, covering the month ended 31 March 2026. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624205698","title":"Shareholders Will Be Pleased With The Quality of Qyuns Therapeutics' (HKG:2509) Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2624205698","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624205698?lang=en_us&edition=fundamental","pubTime":"2026-04-04 06:40","pubTimestamp":1775256021,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. ( HKG:2509 ) just reported healthy earnings but the stock price didn't move much. We think...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/shareholders-will-be-pleased-with-the-quality-of-qyuns-thera","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2509/qyuns-therapeutics-shares/news/shareholders-will-be-pleased-with-the-quality-of-qyuns-thera","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LENZ","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622876838","title":"Qyuns Therapeutics Forms Strategy and Development Committee to Sharpen Long-Term Planning","url":"https://stock-news.laohu8.com/highlight/detail?id=2622876838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622876838?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:22","pubTimestamp":1774624927,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics Co., Ltd. Class H ( ($HK:2509) ) just unveiled an update. Qyuns Therapeutics has created a Strategy and Development Committee un...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-forms-strategy-and-development-committee-to-sharpen-long-term-planning?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/qyuns-therapeutics-forms-strategy-and-development-committee-to-sharpen-long-term-planning?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4596","BK4600","BK4539","3LMI.UK","MSTY.UK","MST","BK4516","MSTW","BK4023","09799","BK4585","WNTR","MSII","IMST","BK4007","MSOO","MTYY","MSTZ","BK4588","09399","MSTK","BK4139","MSTX","APED","02509","LMI3.UK","MSST","MSTY","3SMI.UK","07399","MSTP","MSDD","SMI3.UK","07799","BK4595","SMST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179351235","title":"QYUNS-B Reports Over 400% Revenue Surge in 2025, Swings to Adjusted Profit of 356 Million Yuan","url":"https://stock-news.laohu8.com/highlight/detail?id=1179351235","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179351235?lang=en_us&edition=fundamental","pubTime":"2026-03-27 21:09","pubTimestamp":1774616942,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced its 2025 financial results, reporting revenue of approximately 807 million yuan, an increase of about 4.08 times year-over-year. Gross profit reached about 714 million yuan,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622821910","title":"Qyuns Therapeutics - FY Revenue RMB807 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2622821910","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622821910?lang=en_us&edition=fundamental","pubTime":"2026-03-27 20:46","pubTimestamp":1774615581,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nFWN40F0PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621053696","title":"Qyuns Therapeutics Invests 100 Million Yuan in Wealth Management Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2621053696","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621053696?lang=en_us&edition=fundamental","pubTime":"2026-03-24 13:40","pubTimestamp":1774330813,"startTime":"0","endTime":"0","summary":"Qyuns Therapeutics  said it invested 100 million yuan in a wealth management product offered by Shanghai Pudong Development Bank, according to a Hong Kong bourse filing Monday.Shares of the biopharmaceutical company gained over 3% in afternoon trade Tuesday.The product matures Sept. 23 and offers a guaranteed yield of 0.95% and a floating yield of 0% or 1.05% in the mid range or 1.25% in the high range.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","02509","BK4139","BK4007","BK4539","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621922707","title":"BRIEF-Qyuns Therapeutics Co To Subscribe For PDB Wealth Management Product With RMB100 Million Principal","url":"https://stock-news.laohu8.com/highlight/detail?id=2621922707","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621922707?lang=en_us&edition=fundamental","pubTime":"2026-03-23 23:21","pubTimestamp":1774279285,"startTime":"0","endTime":"0","summary":"BRIEF-Qyuns Therapeutics Co To Subscribe For PDB Wealth Management Product With RMB100 Million PrincipalMarch 23  - Qyuns Therapeutics Co Ltd 2509.HK:TO SUBSCRIBE FOR PDB WEALTH MANAGEMENT PRODUCT WITH RMB100 MILLION PRINCIPALFurther company coverage: 2509.HK ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140999385","title":"QYUNS-B (02509) Invests 100 Million Yuan in Wealth Management Product","url":"https://stock-news.laohu8.com/highlight/detail?id=1140999385","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140999385?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:18","pubTimestamp":1774275495,"startTime":"0","endTime":"0","summary":"QYUNS-B (02509) announced that on March 23, 2026, the company entered into a subscription agreement with SPD Bank to purchase a wealth management product. The move is aimed at efficiently utilizing...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621701610","title":"Qyuns Therapeutics Co Ltd - to Subscribe for Pdb Wealth Management Product With RMB100 Mln Principal","url":"https://stock-news.laohu8.com/highlight/detail?id=2621701610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621701610?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:59","pubTimestamp":1774274355,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nFWN40B0T2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":0.0275},{"period":"1month","weight":-0.1867},{"period":"3month","weight":-0.1686},{"period":"6month","weight":-0.1844},{"period":"1year","weight":0.5543},{"period":"ytd","weight":-0.0863}],"compareEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":0.0006},{"period":"3month","weight":-0.0227},{"period":"6month","weight":-0.0229},{"period":"1year","weight":0.107},{"period":"ytd","weight":0.013}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Qyuns Therapeutics Co Ltd is a China-based company mainly engaged in biopharmaceuticals. The Company is mainly engaged in biotechnology research and development of biological therapies for autoimmune and allergic diseases. The Company's business mainly covers four major disease areas, including skin, rheumatism, respiratory and digestive tract diseases. The Company is developing eight projects, with target indications including psoriasis, atopic dermatitis, rheumatoid arthritis, inflammatory bowel disease and asthma. The Company's core products include QX002N and QX005N.","exchange":"SEHK","name":"QYUNS-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"QYUNS-B(02509),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest QYUNS-B(02509) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"QYUNS-B,02509,QYUNS-B股票,QYUNS-B股票老虎,QYUNS-B股票老虎国际,QYUNS-B行情,QYUNS-B股票行情,QYUNS-B股价,QYUNS-B股市,QYUNS-B股票价格,QYUNS-B股票交易,QYUNS-B股票购买,QYUNS-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"QYUNS-B(02509),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest QYUNS-B(02509) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}